ArticleOPEN ACCESS

Top advances of the year: Hepatobiliary cancers

Cancer
DOI: 10.1002/cncr.34652
5Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This commentary reviews top advances in hepatobiliary cancer research in 2021–2022, focusing on leveraging immunotherapeutics in combination with other therapies earlier in the disease course and targeted to patient's individualized biomarkers that may predict response or resistance to checkpoint inhibitors.

Author supplied keywords

Cite

CITATION STYLE

APA

Coffman-D’Annibale, K. L., & Greten, T. F. (2023, April 15). Top advances of the year: Hepatobiliary cancers. Cancer. John Wiley and Sons Inc. https://doi.org/10.1002/cncr.34652

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free